For example, cytokines such as interleukin-2 (IL-2) have been demonstrated to stimulate the immune system [65] and favourable responses to IL-2 therapy have been demonstrated in patients with metastatic melanoma and renal cell cancer [66]. This evidence concerns the gene IL2 and metastatic melanoma.